These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 12717400)

  • 1. Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line.
    Zhu H; Zhao H; Collins CD; Eckenrode SE; Run Q; McIndoe RA; Crawford JM; Nelson DR; She JX; Liu C
    Hepatology; 2003 May; 37(5):1180-8. PubMed ID: 12717400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT3 induces anti-hepatitis C viral activity in liver cells.
    Zhu H; Shang X; Terada N; Liu C
    Biochem Biophys Res Commun; 2004 Nov; 324(2):518-28. PubMed ID: 15474458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the CXCR3 ligand I-TAC by hepatocytes in chronic hepatitis C and its correlation with hepatic inflammation.
    Helbig KJ; Ruszkiewicz A; Semendric L; Harley HA; McColl SR; Beard MR
    Hepatology; 2004 May; 39(5):1220-9. PubMed ID: 15122750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus inhibits intracellular interferon alpha expression in human hepatic cell lines.
    Zhang T; Lin RT; Li Y; Douglas SD; Maxcey C; Ho C; Lai JP; Wang YJ; Wan Q; Ho WZ
    Hepatology; 2005 Oct; 42(4):819-27. PubMed ID: 16175599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer cells inhibit hepatitis C virus expression.
    Li Y; Zhang T; Ho C; Orange JS; Douglas SD; Ho WZ
    J Leukoc Biol; 2004 Dec; 76(6):1171-9. PubMed ID: 15339939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the nonstructural protein 4B of hepatitis C virus as a factor that inhibits the antiviral activity of interferon-alpha.
    Xu J; Liu S; Xu Y; Tien P; Gao G
    Virus Res; 2009 Apr; 141(1):55-62. PubMed ID: 19185598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral action of interferon-alpha against hepatitis C virus replicon and its modulation by interferon-gamma and interleukin-8.
    Jia Y; Wei L; Jiang D; Wang J; Cong X; Fei R
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1278-85. PubMed ID: 17565587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon alpha decreases expression of human scavenger receptor class BI, a possible HCV receptor in hepatocytes.
    Murao K; Imachi H; Yu X; Cao WM; Nishiuchi T; Chen K; Li J; Ahmed RA; Wong NC; Ishida T
    Gut; 2008 May; 57(5):664-71. PubMed ID: 17998316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Investigating the inhibitory effects of interferon-alpha on the replication of hepatitis C virus replicon].
    Jia YT; Wei L; Jiang D; Cong X; Fei R
    Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(29):2065-9. PubMed ID: 16313804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-stranded RNA-activated protein kinase inhibits hepatitis C virus replication but may be not essential in interferon treatment.
    Chang JH; Kato N; Muroyama R; Taniguchi H; Guleng B; Dharel N; Shao RX; Tateishi K; Jazag A; Kawabe T; Omata M
    Liver Int; 2010 Feb; 30(2):311-8. PubMed ID: 19840259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus core protein modulates the interferon-induced transacting factors of Jak/Stat signaling pathway but does not affect the activation of downstream IRF-1 or 561 gene.
    Basu A; Meyer K; Ray RB; Ray R
    Virology; 2001 Sep; 288(2):379-90. PubMed ID: 11601909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New antiviral pathway that mediates hepatitis C virus replicon interferon sensitivity through ADAR1.
    Taylor DR; Puig M; Darnell ME; Mihalik K; Feinstone SM
    J Virol; 2005 May; 79(10):6291-8. PubMed ID: 15858013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ME3738 enhances the effect of interferon and inhibits hepatitis C virus replication both in vitro and in vivo.
    Abe H; Imamura M; Hiraga N; Tsuge M; Mitsui F; Kawaoka T; Takahashi S; Ochi H; Maekawa T; Hayes CN; Tateno C; Yoshizato K; Murakami S; Yamashita N; Matsuhira T; Asai K; Chayama K
    J Hepatol; 2011 Jul; 55(1):11-8. PubMed ID: 21145867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD8+ T-cell interaction with HCV replicon cells: evidence for both cytokine- and cell-mediated antiviral activity.
    Liu C; Zhu H; Tu Z; Xu YL; Nelson DR
    Hepatology; 2003 Jun; 37(6):1335-42. PubMed ID: 12774012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The direct antiviral effect of interferon-gamma on hepatitis C virus replicon].
    Jia YT; Wei L; Jiang D; Cong X; Fei R
    Zhonghua Gan Zang Bing Za Zhi; 2006 Jan; 14(1):7-10. PubMed ID: 16420756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of hepatitis C virus core protein inhibits interferon-induced nuclear import of STATs.
    Melén K; Fagerlund R; Nyqvist M; Keskinen P; Julkunen I
    J Med Virol; 2004 Aug; 73(4):536-47. PubMed ID: 15221897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of antiviral activity against hepatitis C virus in vitro by interferon combination therapy.
    Okuse C; Rinaudo JA; Farrar K; Wells F; Korba BE
    Antiviral Res; 2005 Jan; 65(1):23-34. PubMed ID: 15652968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of hepatitis C virus replicon cell lines possessing interferon-resistant phenotype.
    Namba K; Naka K; Dansako H; Nozaki A; Ikeda M; Shiratori Y; Shimotohno K; Kato N
    Biochem Biophys Res Commun; 2004 Oct; 323(1):299-309. PubMed ID: 15351737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional significance of globotriaosyl ceramide in interferon-alpha(2)/type 1 interferon receptor-mediated antiviral activity.
    Khine AA; Lingwood CA
    J Cell Physiol; 2000 Jan; 182(1):97-108. PubMed ID: 10567921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver expression of proteins controlling interferon-mediated signalling as predictive factors in the response to therapy in patients with hepatitis C virus infection.
    Bautista D; Bermúdez-Silva FJ; Lasarte JJ; Rodriguez-Fonseca F; Baixeras E
    J Pathol; 2007 Nov; 213(3):347-55. PubMed ID: 17940994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.